Description:

Traditional treatment with eye drops for glaucoma can contribute to ocular surface disease (OSD). It is important that all clinicians treating glaucoma also diagnose and treat ocular surface disease to increase patient comfort and compliance, and prevent worsening OSD. We will review non-drop options such as SLT, intracameral implants and minimally invasive glaucoma surgery (MIGS) and how they fit into the treatment protocol for patients with glaucoma and OSD.

Course Code:

AOA381-GL

Speaker(s):

Ahmad Fahmy, O.D.

amfahmy1@gmail.com

Hardeep Kataria, O.D.

kataria.hardeep@gmail.com

Credits:

1

AOA Expiration Date:

3/13/2026

Related News

‘Profits over patients cannot continue’ with VBMs; Texas testifies at health insurance hearing

As Texas defends its landmark law curbing vision benefit managers (VBMs), doctors of optometry testify at a hearing on the state’s health insurance market.

Kentucky attorney general holds Warby Parker accountable for its online vision test

Enduring advocacy by the Kentucky Optometric Association regarding retailer’s online eye test shows results as its state attorney general reaches settlement with Warby Parker that results in a fine announced May 10.

Next-gen optometry’s focus on independent practice

Preparing optometry students for practice autonomy is an imperative the AOA doesn’t take lightly, doubling down with partnering academic institutions for the profession’s future.